Optimum Therapeutics (United States)

Recent papers from Optimum Therapeutics (United States)

1. Environmental associations with heart-rate responses during field-based submaximal fitness testing in female football players: an exploratory multi-centre studyScience and Medicine in Football · 2026
2. Prevalence and healthcare utilization of eosinophilic chronic obstructive pulmonary disease in the UK: an observational electronic health record-based cohort studyRespiratory Research · 2026
3. Contrastive Structured Detection and Quantum Exploration for Zero-Day Threat Detection2026
4. Configuring knowledge management and big data analytics for supply chain resilience: a set-theoretic analysis of Ghanaian free zone manufacturersVINE Journal of Information and Knowledge Management Systems · 2026
5. Early-night core body temperature decline is associated with sleep fragmentation and early-night slow-wave sleep duration in elite swimmersTemperature · 2026
6. Number and type of food additives in plant-based vs animal-based products: an analysis of a UK supermarket rangeFood Additives & Contaminants Part A · 2026
7. Rapid tests for Bundibugyo virus in DR CongoThe Lancet · 2026
8. Developing consensus on competency-based educational standards in orthopaedic manual physical therapy fellowship training: part 2: knowledge for specialty practice and professionalismJournal of Manual & Manipulative Therapy · 2026
9. Puxitatug samrotecan (AZD8205) vs chemotherapy in patients with B7-H4–selected advanced/metastatic endometrial cancer: The phase 3 randomized Bluestar-Endometrial01 (BE01)/GOG-3110/ENGOT-EN28 trial.Journal of Clinical Oncology · 2026
10. Updated safety and efficacy of puxitatug samrotecan (Puxi-Sam, AZD8205) in patients (pts) with endometrial cancer (EC) or ovarian cancer (OC): Phase 1/2a BLUESTAR study.Journal of Clinical Oncology · 2026
11. B77-02 LPA1 Antagonism by PIPE-791 Reduces Alveolar Epithelial Cell Apoptosis In VitroAmerican Journal of Respiratory and Critical Care Medicine · 2026
12. B77-01 PIPE-791 and BMS-986278: Two Lysophosphatidic Acid Receptor 1 (lpa1) Antagonists With Distinct Lung Occupancy Profiles and Vascular EffectsAmerican Journal of Respiratory and Critical Care Medicine · 2026
13. C33-03 Long-Term Clinical Impact of 12-Month Remission After Biologic Therapy in Patients With Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine · 2026
14. C14-07 Remission After Biologic Therapy Initiation in Patients With Severe Asthma: An Evaluation of up to 5 Years of Follow-up in the International Severe Asthma RegistryAmerican Journal of Respiratory and Critical Care Medicine · 2026
15. A32-09 Beclometasone/Formoterol (BDP/FF) Is Non-inferior to Budesonide/Formoterol (BUD/FF) as Maintenance and Reliever Therapy (MART) and Reduces Inhaler-related GHG Emissions in Adult AsthmaAmerican Journal of Respiratory and Critical Care Medicine · 2026
16. Communication as clinical intervention in urologyBritish Journal of Nursing · 2026
17. Validation of Rightmate Precision Mating in Simmental Seedstock Beef Herds Shows Increased Rates of Genetic ProgressJournal of Animal Science · 2026
18. Identifying predictors and measuring variation in hospitalisation for older adult care home residents: a retrospective cohort study using routinely collected dataAge and Ageing · 2026
19. Hybrid Cloud, Cybersecurity, and Artificial Intelligence in Healthcare: A Strategic Convergence for U.S. Critical Infrastructure and National Competitiveness2026
20. Hybrid Cloud, Cybersecurity, and Artificial Intelligence in Healthcare: A Strategic Convergence for U.S. Critical Infrastructure and National Competitiveness2026